IL15 and cancer: For example, CD56bright cells can acquire cytotoxic activity after IL-15 priming, hepatic CD56bright NK cells show reduced cytokine secretion despite their phenotype, uterine CD56superbright cells promote angiogenesis and tissue remodeling (88), and CD56-CD16+ have been shown to expand in cancer (89).